Clinical characteristics | NEO1 expression | Chi-square | P value | ||
---|---|---|---|---|---|
Total | High | Low | |||
Gender | |||||
 Male | 106 | 50 | 56 | 0.715 | 0.398 |
 Female | 96 | 51 | 45 | ||
Age | |||||
 < 65 | 87 | 46 | 41 | 0.505 | 0.477 |
 ≥65 | 115 | 55 | 60 | ||
T stage | |||||
 T1-T2 | 40 | 27 | 13 | 6.11 | 0.013* |
 T3-T4 | 162 | 74 | 88 | ||
N stage | |||||
 N0 | 101 | 50 | 51 | 0.02 | 0.888 |
 N1-N2 | 101 | 51 | 50 | ||
M stage | |||||
  M0 | 138 | 77 | 61 | 5.855 | 0.016* |
  M1 | 64 | 24 | 40 | ||
Clinical stage | |||||
 I | 30 | 21 | 9 | 5.637 | 0.018* |
  II–IV | 172 | 80 | 92 | ||
Recurrence | |||||
 Yes | 39 | 13 | 26 | 9.135 | 0.003** |
 No | 116 | 71 | 45 | ||
Microsattelite instability | |||||
 pMMR | 145 | 66 | 79 | 3.749 | 0.053 |
 dMMR | 38 | 24 | 14 | ||
p53 mutation status | |||||
 Mutant | 99 | 49 | 50 | 0.319 | 0.572 |
 Wild-type | 58 | 26 | 32 |